Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repetitive Levosimendan in Severe Systolic Heart Failure
NCT03764722Phase 4Unknown
- Sponsor
- Collegium Medicum of Nicolaus Copernicus University in Bydgoszcz
- Start
- Aug 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levosimendan, sponsored by Collegium Medicum of Nicolaus Copernicus University in Bydgoszcz. Status: unknown.
02
Drugs
levosimendan
Beyond the preview
Go deeper on NCT03764722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03764722.